These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3168342)

  • 21. Cardiac complications in beta-thalassemia: From mice to men.
    Kumfu S; Fucharoen S; Chattipakorn SC; Chattipakorn N
    Exp Biol Med (Maywood); 2017 Jun; 242(11):1126-1135. PubMed ID: 28485683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Echocardiographic and polycardiographic findings in multiple-transfused patients with thalassemia major].
    Orlandi G; Sticca M; Zanini R; Caminiti A
    Pediatr Med Chir; 1982; 4(1-2):61-4. PubMed ID: 7111041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary myocardial dysfunction in autosomal dominant EDMD. A tissue doppler and cardiovascular magnetic resonance study.
    Smith GC; Kinali M; Prasad SK; Bonne G; Muntoni F; Pennell DJ; Nihoyannopoulos P
    J Cardiovasc Magn Reson; 2006; 8(5):723-30. PubMed ID: 16891232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrocardiographic abnormalities in thalassemia patients with heart failure.
    Mancuso L; Mancuso A; Bevacqua E; Rigano P
    Cardiovasc Hematol Disord Drug Targets; 2009 Mar; 9(1):29-35. PubMed ID: 19275575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Echocardiographic follow-up in latent cardiomyopathy].
    Curtius JM; Stechern V; Kuhn H; Loogen F
    Z Kardiol; 1984 Nov; 73(11):695-700. PubMed ID: 6523968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Severe cardiomyopathy in a woman with intermediate beta-thalassemia. Regression of cardiac failure with desferrioxamine].
    Mancuso L; Iacona MA; Marchi S; Rigano P; Geraci E
    G Ital Cardiol; 1985 Sep; 15(9):916-20. PubMed ID: 4085735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Five Years of Deferasirox Therapy for Cardiac Iron in β-Thalassemia Major.
    Vlachaki E; Agapidou A; Spanos G; Klonizakis P; Vetsiou E; Mavroudi M; Boura P
    Hemoglobin; 2015; 39(5):299-304. PubMed ID: 26177199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship of magnetic resonance imaging estimation of myocardial iron to left ventricular systolic and diastolic function in thalassemia.
    Leonardi B; Margossian R; Colan SD; Powell AJ
    JACC Cardiovasc Imaging; 2008 Sep; 1(5):572-8. PubMed ID: 19356483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myocardial dysfunction and adrenergic innervation in patients with Type 1 diabetes mellitus.
    Scognamiglio R; Casara D; Avogaro A
    Diabetes Nutr Metab; 2000 Dec; 13(6):346-9. PubMed ID: 11232760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regression of myocardial dysfunction after switching from desferrioxamine to deferiprone therapy in beta-thalassemia major patients.
    Huang YC; Chang JS; Wu KH; Peng CT
    Hemoglobin; 2006; 30(2):229-38. PubMed ID: 16798648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between right ventricular T
    Jellis CL; Yingchoncharoen T; Gai N; Kusunose K; Popović ZB; Flamm S; Kwon D
    Int J Cardiovasc Imaging; 2018 Jan; 34(1):55-65. PubMed ID: 28357724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relation between iron-overload indices, cardiac echo-Doppler, and biochemical markers in thalassemia intermedia.
    Isma'eel H; Chafic AH; El Rassi F; Inati A; Koussa S; Daher R; Gharzuddin W; Alam S; Taher A
    Am J Cardiol; 2008 Aug; 102(3):363-7. PubMed ID: 18638603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of L-type calcium channel blocker (amlodipine) on myocardial iron deposition in patients with thalassaemia with moderate-to-severe myocardial iron deposition: protocol for a randomised, controlled trial.
    Shakoor A; Zahoor M; Sadaf A; Alvi N; Fadoo Z; Rizvi A; Quadri F; Tipoo FA; Khurshid M; Sajjad Z; Colan S; Hasan BS
    BMJ Open; 2014 Dec; 4(12):e005360. PubMed ID: 25492271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cardiac dysfunction in children with thalassemia major].
    Angelika L; Graf N; Hoffmann W
    Klin Padiatr; 1988; 200(2):102-7. PubMed ID: 3386182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of the cardiovascular complications of thalassemia by echocardiography.
    Walker JM; Nair S
    Ann N Y Acad Sci; 2010 Aug; 1202():165-72. PubMed ID: 20712789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac complications in thalassemia: noninvasive detection methods and new directions in the clinical management.
    Mancuso L; Panzarella G; Bartolotta TV; Midiri M; Renda D; Maggio A
    Expert Rev Cardiovasc Ther; 2003 Sep; 1(3):439-52. PubMed ID: 15030271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iron and oxidative stress in cardiomyopathy in thalassemia.
    Berdoukas V; Coates TD; Cabantchik ZI
    Free Radic Biol Med; 2015 Nov; 88(Pt A):3-9. PubMed ID: 26216855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance.
    Anderson LJ; Westwood MA; Holden S; Davis B; Prescott E; Wonke B; Porter JB; Walker JM; Pennell DJ
    Br J Haematol; 2004 Nov; 127(3):348-55. PubMed ID: 15491298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac time intervals by tissue Doppler imaging M-mode echocardiography: reproducibility, reference values, association with clinical characteristics and prognostic implications.
    Biering-Sørensen T
    Dan Med J; 2016 Aug; 63(8):. PubMed ID: 27477801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diabetic cardiomyopathy in preclinical phase. Polycardiographic and echocardiographic study (author's transl)].
    Roda L; Patessio A; Neri V; Tisi C; Ferrari A; Ricci A
    G Ital Cardiol; 1980; 10(10):1299-307. PubMed ID: 7239076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.